返回
Entera Bio Ltd（ENTX）價格
ENTX 股價走勢圖
ENTX 收益
Entera Bio Ltd
$1.62
2.53%
$0.04
收盤價：Jan 16, 16:00:00 GMT-5
$1.62
0%
$0
盤前：Jan 20, 08:39:12 GMT-5
關鍵數據
前收市價
$1.58
開盤價
$1.59
當日範圍
$1.59 - $1.66
52週區間
$1.45 - $3.22
交易量
137.0K
平均成交量
208.5K
每股盈餘 (TTM)
-0.24
股息收益率
--
市值
$74.2M
什麼是 ENTX？
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. The firm developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.